Genesis Medical Vision Overview
Genesis Medical is pioneering a groundbreaking approach to AI in radiology. Employing a non-statistical, clinical AI-education methodology that emulates the logic and intuition of an expert physician, needing only a tiny number of scans to achieve high accuracy with near-zero false positives
Cumulative Funding Raised Over Time ($)
Latest News
growth-positive
Clinical adoption of AI-based products in lung cancer screening: barriers to market entry, and a comparative, multi-center, cross-European study. - ADRES biopharma regulatory consulting
Genesis Medical Vision, an Israeli company, is developing an AI platform for early cancer detection. The company has pioneered a new AI approach, deep IIMM technology, which mimics physician logic and intuition. Genesis has completed a clinical trial with its G4Lungs product, showing promising results for automated lung cancer screening. The company has partnered with i-DNA, a Dutch research organization, to participate in a large comparative study involving major European screening programs. This collaboration aims to overcome technological barriers and facilitate the clinical adoption of AI in lung cancer screening, potentially expanding to strategic markets like the US.
Partners
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $2.71M |
| Last funding | $500K |
| Stage | Pre-Seed |
| Rounds | 4 |
| Investors | 2 |
Team Members
6
Employees: 1-10
Web & Social Links
| Website | genesis-medical.ai/ |
Locations
Ha-Menofim St 10, Herzliya, 4672561, Israel
Photos & Videos
1 item(s)
